A deeper understanding of the inflammatory processes driving psoriasis and psoriatic arthritis is translating into new research approaches that could potentially benefit patients. Psoriasis is a ...

In a recent Japanese Society for Psoriasis Research analysis of 28,628 cases, herbal medicines (14.5%) ranked highest among systemic therapies used. This was followed by etretinate (7.6%), NSAIDs ...

ORLANDO, Fla. — Of the 12 biologics in four drug classes approved for treating psoriasis in the United States, interleukin 23 (IL-23) inhibitors might be exceptional, particularly if used early ...

Psoriasis is a skin condition that affects almost 2 million people in the UK. It is characterised by red, flaky patches of skin. These may be itchy or painful, or both, and can affect any part of ...